Health chiefs row back on plan to limit Covid-19 drug in Irish market after complaints from Pfizer

Health chiefs have rowed back on plans to limit a ­“game-changer” drug to treat Covid-19 from drugs giant Pfizer after the company complained to the chief medical officer (CMO).